MediPharma Times Drug Approval

AstraZeneca India Gets CDSCO Green Light for New Use of Osimertinib in Advanced EGFR-Mutated Lung Cancer

In a major stride for lung cancer treatment in India, AstraZeneca India Pharma has secured approval…

Continue Reading